Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
- Posted on November 26, 2024
- Your Feed Science
- By The New York Times
- 4 Views
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease. continue reading...
